[1]
“Bimekizumab Clinical Efficacy in Important Body Regions and Health-related Quality of Life in Patients with Plaque Psoriasis: Data from Four Phase 3/3b Comparator-controlled Trial Periods ”, J of Skin, vol. 8, no. 6, p. s434, Nov. 2024, doi: 10.25251/skin.8.supp.434.